1. Desai PV, Krepostman N, Collins M, De Sirkar S, Hinkleman A, Walsh K, et al. Neurological complications of pulmonary embolism: a literature review. Curr Neurol Neurosci Rep. 2021;21(10):59. [DOI:10.1007/s11910-021-01145-8]

2. Beitland S, Wimmer H, Lorentsen T, Jacobsen D, Draegni T, Brunborg C, et al. Venous thromboembolism in the critically ill: a prospective observational study of occurrence, risk factors, and outcome. Acta Anaesthesiol Scand. 2019;63(5):630-8. [DOI:10.1111/aas.13316]

3. Sandblad KG, Rosengren A, Sorbo J, Jern S, Hansson PO. Pulmonary embolism and deep vein thrombosis-comorbidities and temporary provoking factors in a register-based study of 1.48 million people. Res Pract Thromb Haemost. 2022;6(4):e12714. [DOI:10.1002/rth2.12714]

4. Vrettou CS, Dima E, Sigala I. Pulmonary embolism in critically ill patients-prevention, diagnosis, and management. Diagnostics. 2024;14(19):2208. [DOI:10.3390/diagnostics14192208]

5. Price CP, Fay M, Hopstaken RM. Point-of-care testing for D-dimer in the diagnosis of venous thromboembolism in primary care: a narrative review. Cardiol Ther. 2021;10(1):27-40. [DOI:10.1007/s40119-020-00206-2]

6. Chen S, Zhang D, Zheng T, Yu Y, Jiang J. DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis. 2021;51(1):33-9. [DOI:10.1007/s11239-020-02181-w]

7. Cohen SL, Gianos E, Barish MA, Chatterjee S, Kohn N, Lesser M, et al. Prevalence and predictors of venous thromboembolism or mortality in hospitalized COVID-19 patients. Thromb Haemost. 2021;121(8):1043-53. [DOI:10.1055/a-1366-9656]

8. Aharoni M, Horesh N, Rogowski O, Kremer A, Mayan H, Justo D. Unprovoked pulmonary embolism in older adults: incidence and prognosis. Arch Med Sci. 2021;17(2):337-42. [DOI:10.5114/aoms/90673]

9. Fazzari F, Baggiano A, Fusini L, Ghulam Ali S, Gripari P, Junod D, et al. Early biological valve failure: structural valve degeneration, thrombosis, or endocarditis? J Clin Med. 2023;12(17):5740. [DOI:10.3390/jcm12175740]

10. Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, et al. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci. 2023;24(4):3169. [DOI:10.3390/ijms24043169]

11. Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023;20(4):248-62. [DOI:10.1038/s41569-022-00787-6]

12. Khubdast S, Jalilian M, Rezaeian S, Abdi A, Khatony A. Prevalence and factors related to venous thromboembolism in patients admitted to critical care units: a systematic review and meta-analysis. J Vasc Nurs. 2023;41(4):186-94. [DOI:10.1016/j.jvn.2023.06.008]

13. Lichota A, Szewczyk EM, Gwozdzinski K. Factors affecting the formation and treatment of thrombosis by natural and synthetic compounds. Int J Mol Sci. 2020;21(21):7975. [DOI:10.3390/ijms21217975]

14. Koo CM, Vissapragada R, Sharp R, Nguyen P, Ung T, Solanki C, et al. ABO blood group-related venous thrombosis risk in patients with peripherally inserted central catheters. Br J Radiol. 2018;91(1082):20170560. [DOI:10.1259/bjr.20170560]

15. Onwuzo C, Olukorode J, Sange W, Tanna SJ, Osaghae OW, Hassan A, et al. A review of preventive strategies for venous thromboembolism in hospitalized patients. Cureus. 2023;15(11):e48421. [DOI:10.7759/cureus.48421]

16. Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Prevention, diagnosis, and treatment of venous thromboembolism in patients with COVID-19: CHEST guideline and expert panel report. Chest. 2020;158(3):1143-63. [DOI:10.1016/j.chest.2020.05.559]

17. Porfidia A, Pola R. Venous thromboembolism in COVID-19 patients. J Thromb Haemost. 2022;18(6):1516-1517. [DOI:10.1111/jth.14842]

18. Nkoke C, Ngueping MJT, Atemkeng F, Teuwafeu D, Boombhi J, Menanga A. Incidence of venous thromboembolism, risk factors, and prophylaxis in hospitalized patients in the southwest region of Cameroon. Vasc Health Risk Manag. 2020;16:317-24. [DOI:10.2147/VHRM.S205935]

19. Wang T-F, Wong CA, Milligan PE, Thoelke MS, Woeltje KF, Gage BF. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis. Thromb Res. 2014;133(1):25-9. [DOI:10.1016/j.thromres.2013.09.011]

20. Akbari A, Haghpanah S, Barzegar H, Shahsavani A, Afrasiabi A, Parand S, et al. Epidemiologic study of patients with thrombotic events referred to a tertiary hospital in southern Iran. Heliyon. 2021;7(8):e07734. [DOI:10.1016/j.heliyon.2021.e07734]

21. Fariba F, Jiryaee N, Neshatyar C, Tarbiat M. Evaluation of the frequency of risk factors in venous thromboembolic patients admitted to Ekbatan and Farshchian hospitals in Hamadan from 2012 to 2017. Avicenna J Clin Med. 2019;26(1):60-6.[Persian] [DOI:10.29252/ajcm.26.1.60]

22. Mousa BR, Mahdy NE, Mahmoud SF, Mohamed MG. Risk factors for deep venous thrombosis among patients admitted to the vascular unit. Egypt J Health Care. 2022;13(2):270-86. [DOI:10.21608/ejhc.2022.229290]

23. Alamri AS, Alamri MS, Al-Qahatani F, Alamri AS, Alghuthaymi AM, Alamri AM, et al. Prevalence and risk factors of deep vein thrombosis among adult surgical patients in Aseer Central Hospital, Saudi Arabia. Cureus. 2023;15(10):e47728. [DOI:10.7759/cureus.47856]

24. Tian Q, Li M. Risk factors of deep vein thrombosis of the lower extremity in patients undergoing gynecological laparoscopic surgery: what should we care about? BMC Womens Health. 2021;21:1-6. [DOI:10.1186/s12905-021-01276-7]

25. Cushman M, O'Meara ES, Heckbert SR, Zakai NA, Rosamond W, Folsom AR. Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology. Thrombosis research. 2016 Aug 1; 144:127-32. [DOI:10.1016/j.thromres.2016.06.012]

26. Cohen SL, Gianos E, Barish MA, Chatterjee S, Kohn N, Lesser M, et al. Prevalence and predictors of venous thromboembolism or mortality in hospitalized COVID-19 patients. Thromb Haemost. 2021;121(8):1043-53. [DOI:10.1055/a-1366-9656]

27. Nagler M, Van Kuijk SM, Ten Cate H, Prins MH, Ten Cate-Hoek AJ. Predicting recurrent venous thromboembolism in patients with deep-vein thrombosis: development and internal validation of a potential new prediction model (Continu-8). Front Cardiovasc Med. 2021;8:655226. [DOI:10.3389/fcvm.2021.655226]

28. Ren Z, Yuan Y, Qi W, Li Y, Wang P. The incidence and risk factors of deep venous thrombosis in lower extremities following surgically treated femoral shaft fracture: a retrospective case-control study. J Orthop Surg Res. 2021;16(1):446. [DOI:10.1186/s13018-021-02595-z]

29. Miri M, Goharani R, Sistanizad M. Deep vein thrombosis among intensive care unit patients: an epidemiologic study. Emergency. 2017;5(1):e13.

30. Lawall H, Oberacker R, Zemmrich C, Bramlage P, Diehm C, Schellong SM. Prevalence of deep vein thrombosis in acutely admitted ambulatory non-surgical intensive care unit patients. BMC Res Notes. 2014;7:1-6. [DOI:10.1186/1756-0500-7-431]

31. Tormene D, Ferri V, Carraro S, Simioni P. Gender and the risk of venous thromboembolism. InSeminars in thrombosis and hemostasis 2011 Apr (Vol. 37, No. 03, pp. 193-198). © Thieme Medical Publishers. [DOI:10.1055/s-0031-1273083]

32. Tagalakis V, Kondal D, Ji Y, Boivin JF, Moride Y, Ciampi A, Kahn SR. Men had a higher risk of recurrent venous thromboembolism than women: a large population study. Gender medicine. 2012 Feb 1;9(1):33-43. [DOI:10.1016/j.genm.2011.12.002]

33. Olie V, Zhu T, Martinez I, Scarabin P-Y, Emmerich J. Sex-specific risk factors for recurrent venous thromboembolism. Thromb Res. 2012;130(1):16-20. [DOI:10.1016/j.thromres.2011.10.026]